JPMorgan Chase gives HCA neutral rating — 5 notes

JPMorgan Chase began coverage on HCA shares and issued the company a neutral rating, according to The Legacy.

Advertisement

Here are five notes:

1. The brokerage firm gave HCA a target price of $98.00.

2. The shares opened at $82.24 on Wed., Sept. 16.

3. HCA has a 52-week low of $43.91 and a 52-week high of $95.49.

4. The company has a 50-moving average of $87.76 and a 200-day moving average of $83.31.

5. HCA has a market cap of $34.15 billion and P/E ratio of 16.84.

More articles on surgery centers:
SCA price target updated to $39.75: 4 things to know
Tenet shares drop 5% — 5 key notes
Surgery Partners valued at $1.25B, SCA shares rise 4.9% & more — 5 key notes on ASC companies

Advertisement

Next Up in ASC Transactions & Valuation Issues

  • Outpatient care remains one of healthcare’s hottest investment targets in 2026. From new multimillion-dollar ASC builds to joint venture partnerships,…

  • Tenet’s ASC arm, United Surgical Partners International, is positioning itself for a new growth runway as Medicare begins phasing out…

  • Certificate-of-need laws remain one of the biggest regulatory forces shaping where and how ASCs can grow, and the landscape is…

Advertisement

Comments are closed.